Sinoma Science & Technology Co.,Ltd. (002080.SZ)
CNY 13.12
(-2.31%)
CNY 13.12
(-2.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 25.88 Billion | 22.1 Billion | 20.29 Billion | 18.71 Billion | 13.59 Billion | 11.44 Billion |
| Cost of Revenue | 19.73 Billion | 16.46 Billion | 14.2 Billion | 13.63 Billion | 9.93 Billion | 8.36 Billion |
| Gross Profit | 6.15 Billion | 5.64 Billion | 6.08 Billion | 5.07 Billion | 3.65 Billion | 3.08 Billion |
| Operating Expenses | 3.17 Billion | 2.28 Billion | 2.15 Billion | 2.06 Billion | 1.67 Billion | 1.45 Billion |
| Selling, General and Administrative Expenses | 1.68 Billion | 537.67 Million | 532.97 Million | 553.23 Million | 705.22 Million | 564.02 Million |
| Research and Development Expenses | 1.32 Billion | 1.05 Billion | 961.48 Million | 957.62 Million | 514.76 Million | 355.97 Million |
| Other Expenses | 56.73 Million | 685.77 Million | 657.17 Million | 558.19 Million | 450.89 Million | -112.01 Million |
| Cost and Expenses | 22.9 Billion | 18.74 Billion | 16.35 Billion | 15.7 Billion | 11.6 Billion | 9.81 Billion |
| Operating Income | 2.98 Billion | 4.06 Billion | 4.09 Billion | 2.32 Billion | 2.09 Billion | 1.29 Billion |
| Interest Expense | 404.66 Million | 497.18 Million | 459.03 Million | 391.39 Million | 365.06 Million | 344.33 Million |
| Income Tax Expense | 321.7 Million | 334.58 Million | 648.51 Million | 380.66 Million | 237.07 Million | 186.68 Million |
| Earnings before Tax | 3.03 Billion | 4.06 Billion | 4.12 Billion | 2.34 Billion | 1.66 Billion | 1.17 Billion |
| Net Income | 2.22 Billion | 3.57 Billion | 3.37 Billion | 2.03 Billion | 1.37 Billion | 934.14 Million |
| Earnings Per Share Basic | 1.33 | 2.13 | 2.01 | 1.22 | 0.82 | 0.72 |
| Earnings Per Share Diluted | 1.33 | 2.13 | 2.01 | 1.22 | 0.82 | 0.72 |
| Weighted Average Shares Outstanding | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.29 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.29 Billion |
| Gross Margin | 0.24 | 0.26 | 0.30 | 0.27 | 0.27 | 0.27 |
| EBIT Margin | 0.20 | 0.23 | 0.26 | 0.22 | 0.23 | 0.21 |
| Profit Margin | 0.09 | 0.16 | 0.17 | 0.11 | 0.10 | 0.08 |
| EBITDA | 5.28 Billion | 6.38 Billion | 5.87 Billion | 3.84 Billion | 3.16 Billion | 2.35 Billion |
| Earnings Before Tax Margin | 0.12 | 0.18 | 0.20 | 0.12 | 0.15 | 0.11 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 6.27 Billion | 6.05 Billion | 4.38 Billion | 25.67 Billion | 7.59 Billion | 5.85 Billion |
| Cost of Revenue | 5.21 Billion | 5.1 Billion | 3.56 Billion | 19.73 Billion | 5.77 Billion | 4.53 Billion |
| Gross Profit | 1.05 Billion | 950.88 Million | 811.89 Million | 5.93 Billion | 1.82 Billion | 1.31 Billion |
| Operating Expenses | 720.27 Million | 703.05 Million | 548.34 Million | 3.01 Billion | 1.2 Billion | 775.41 Million |
| Selling, General and Administrative Expenses | 922.11 Million | 385.78 Million | 345.81 Million | - | 675.28 Million | 761.23 Million |
| Research and Development Expenses | 314.4 Million | 308.78 Million | 205.85 Million | - | 384.46 Million | 354.31 Million |
| Other Expenses | -516.25 Million | -8.48 Million | 3.32 Million | -114.8 Million | -143.35 Million | 38.43 Million |
| Cost and Expenses | 5.93 Billion | 5.8 Billion | 4.11 Billion | 22.74 Billion | 6.97 Billion | 5.31 Billion |
| Operating Income | 201.2 Million | 247.82 Million | 263.54 Million | 2.92 Billion | 620.96 Million | 425.86 Million |
| Interest Expense | 105.88 Million | 87.96 Million | 104 Million | 480.87 Million | 120.63 Million | 96.4 Million |
| Income Tax Expense | 21.41 Million | 51.54 Million | 77.53 Million | 321.7 Million | 31.1 Million | 6.02 Million |
| Earnings before Tax | 208.57 Million | 335.86 Million | 371.93 Million | 3.05 Billion | 737.28 Million | 464.29 Million |
| Net Income | 143.68 Million | 248.43 Million | 216.24 Million | 2.22 Billion | 516.22 Million | 316.15 Million |
| Earnings Per Share Basic | 0.09 | 0.15 | 0.13 | - | 0.31 | 0.19 |
| Earnings Per Share Diluted | 0.09 | 0.15 | 0.13 | - | 0.31 | 0.19 |
| Weighted Average Shares Outstanding | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion | 1.67 Billion |
| Gross Margin | 0.17 | 0.16 | 0.19 | 0.23 | 0.24 | 0.22 |
| EBIT Margin | 0.05 | 0.13 | 0.11 | - | 0.14 | 0.10 |
| Profit Margin | 0.02 | 0.04 | 0.05 | 0.09 | 0.07 | 0.05 |
| EBITDA | 314.46 Million | 769.32 Million | 464.15 Million | - | 1.07 Billion | 569.69 Million |
| Earnings Before Tax Margin | 0.03 | 0.04 | 0.06 | 0.11 | 0.08 | 0.07 |
4406
MEDXF
MKC-V
EBRPF
SHANF
007070